The most proximal signaling event known to occur following engagement of the T cell antigen receptor (TCR) is stimulation of a cascade of protein tyrosine kinases (PTK). Following this, other second messenger pathways are activated leading to the appropriate distal response. Recently there has been considerable attention focussed on how signaling cascades are intergrated. The overall goal of the proposed experiments is to continue the structural and fucntional characterization of SLP-76 and its novel associated protein SAP-130. To achieve this goal, the investigator proposes to address further the biochemical features of SLP-76 by identifying the kinases and phosphatases which regulate its phosphorylation as well as localizing SLP-76 within the cell and determining what other molecules SLP-76 binds.
The second aim i s to investigate further the function of SLP-76 by asking questions regarding the consequence of serine phosphoryaltion of this molecule as well as pursuing the relationship between SLP-76 and vav. Additionally it is proposed to study the tissues and cellular subsets which express SLP-76 and to create a mouse deficient in SLP-76 expression via targeted gene disruption.
The third aim i s to study the biochemistry of SAP-130 by asking about its phosphorylation and protein associations.
The final aim i s to begin to assess SAP-130 function by addressing the consequences of its overexpression and the importance of its tyrosine phosphorylation. Additionally, the investigator is interested in understanding better the functional and biochemical relationship between SAP-130 and SLP-76. It is hoped that these studies will shed further light into the regulation of signal transduction in immune cells and provide data that will be useful in the treatment of diseases related to immune dysfunction.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM053256-05
Application #
2857228
Study Section
Experimental Immunology Study Section (EI)
Program Officer
Mccarthy, Susan A
Project Start
1995-01-01
Project End
1999-07-31
Budget Start
1999-01-01
Budget End
1999-07-31
Support Year
5
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Iowa
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
041294109
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Behrens, Edward M; Koretzky, Gary A (2017) Review: Cytokine Storm Syndrome: Looking Toward the Precision Medicine Era. Arthritis Rheumatol 69:1135-1143
Chang, John T; Ciocca, Maria L; Kinjyo, Ichiko et al. (2011) Asymmetric proteasome segregation as a mechanism for unequal partitioning of the transcription factor T-bet during T lymphocyte division. Immunity 34:492-504
Juntilla, Marisa M; Koretzky, Gary A (2008) Critical roles of the PI3K/Akt signaling pathway in T cell development. Immunol Lett 116:104-10
Jordan, Martha S; Smith, Jennifer E; Burns, Jeremy C et al. (2008) Complementation in trans of altered thymocyte development in mice expressing mutant forms of the adaptor molecule SLP76. Immunity 28:359-69
Hunter, A J; Ottoson, N; Boerth, N et al. (2000) Cutting edge: a novel function for the SLAP-130/FYB adapter protein in beta 1 integrin signaling and T lymphocyte migration. J Immunol 164:1143-7
Myung, P S; Clements, J L; White, D W et al. (2000) In vitro and in vivo macrophage function can occur independently of SLP-76. Int Immunol 12:887-97
Boerth, N J; Sadler, J J; Bauer, D E et al. (2000) Recruitment of SLP-76 to the membrane and glycolipid-enriched membrane microdomains replaces the requirement for linker for activation of T cells in T cell receptor signaling. J Exp Med 192:1047-58
Boerth, N J; Judd, B A; Koretzky, G A (2000) Functional association between SLAP-130 and SLP-76 in Jurkat T cells. J Biol Chem 275:5143-52
Fang, N; Koretzky, G A (1999) SLP-76 and Vav function in separate, but overlapping pathways to augment interleukin-2 promoter activity. J Biol Chem 274:16206-12
Peterson, E J; Latinis, K M; Koretzky, G A (1998) Molecular characterization of a CD95 signaling mutant. Arthritis Rheum 41:1047-53

Showing the most recent 10 out of 30 publications